Abstract
Cells are the fundamental structure composing our bodies and hence cellular decline (called senescence) contributes to ageing. Endogenous and exogenous stresses may induce cellular senescence. Stressors are mainly macromolecule damage events, which include: shortening of chromosome telomeres; non-telomeric DNA damage; excessive mitogenic signals, which may cause DNA damage; and non-genotoxic stress, such as perturbations to chromatin organization.
For many years the analysis of chromatin perturbation as a leading event in triggering senescence has been overlooked. Now, it is well recognized that chromatin DNA packaging is not immune to the ravages of time. All eukaryotes experience changes in chromatin organization and gene-expression patterns as they age. This can be due to perturbation in the function of chromatin modifiers. In this review we will discuss the role in the senescence process of the different types of chromatin modifiers, such as the ATP-dependent chromatin remodelling complexes, the enzymes that covalently modify histone tails and proteins involved in DNA methylation.
Keywords: ATP-dependent chromatin remodeling, histone modification, DNA methylation, heterochromatin, euchromatin, ageing
Current Pharmaceutical Design
Title:Chromatin Modification and Senescence
Volume: 18 Issue: 13
Author(s): Giovanni Di Bernardo, Marilena Cipollaro, Umberto Galderisi
Affiliation:
Keywords: ATP-dependent chromatin remodeling, histone modification, DNA methylation, heterochromatin, euchromatin, ageing
Abstract: Cells are the fundamental structure composing our bodies and hence cellular decline (called senescence) contributes to ageing. Endogenous and exogenous stresses may induce cellular senescence. Stressors are mainly macromolecule damage events, which include: shortening of chromosome telomeres; non-telomeric DNA damage; excessive mitogenic signals, which may cause DNA damage; and non-genotoxic stress, such as perturbations to chromatin organization.
For many years the analysis of chromatin perturbation as a leading event in triggering senescence has been overlooked. Now, it is well recognized that chromatin DNA packaging is not immune to the ravages of time. All eukaryotes experience changes in chromatin organization and gene-expression patterns as they age. This can be due to perturbation in the function of chromatin modifiers. In this review we will discuss the role in the senescence process of the different types of chromatin modifiers, such as the ATP-dependent chromatin remodelling complexes, the enzymes that covalently modify histone tails and proteins involved in DNA methylation.
Export Options
About this article
Cite this article as:
Giovanni Di Bernardo, Marilena Cipollaro, Umberto Galderisi , Chromatin Modification and Senescence, Current Pharmaceutical Design 2012; 18 (13) . https://dx.doi.org/10.2174/138161212799859693
DOI https://dx.doi.org/10.2174/138161212799859693 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Mechanism of Aniline Induced Spleen Toxicity and Neuron Toxicity in Experimental Rat Exposure: A Review
Current Neuropharmacology Phosphoprotein Phosphatase 1 Complexes in Spermatogenesis
Current Molecular Pharmacology Inhibitory Smad7: Emerging Roles in Health and Disease
Current Molecular Pharmacology Current and Future Drug Treatments for Glioblastomas
Current Medicinal Chemistry Targeting MAPK Signalling: Prometheus Fire or Pandoras Box?
Current Pharmaceutical Design Berberine Exerts Anti-cancer Activity by Modulating Adenosine Monophosphate- Activated Protein Kinase (AMPK) and the Phosphatidylinositol 3-Kinase/ Protein Kinase B (PI3K/AKT) Signaling Pathways
Current Pharmaceutical Design Novel Virally Targeted Therapies of EBV-Associated Tumors
Current Cancer Drug Targets Early Life Vitamin D Status and Lung Development
Current Respiratory Medicine Reviews Signal Transduction Therapy of Diabetic Vascular Complication
Current Signal Transduction Therapy Effects of PPARγ Ligands on Vascular Tone
Current Molecular Pharmacology MicroRNAs: Modulators of Cell Identity, and their Applications in Tissue Engineering
MicroRNA Peptide Activators of the p53 Tumor Suppressor
Current Pharmaceutical Design Ocular Toxicities in Cancer Therapy: Still Overlooked
Current Cancer Therapy Reviews The Impact of In Vitro Fertilization on the Health of the Mother and the Offspring
Current Women`s Health Reviews Role of Genetics and Epigenetics in Mucosal, Uveal, and Cutaneous Melanomagenesis
Anti-Cancer Agents in Medicinal Chemistry IP6 in Cancer Therapy: Past, Present and Future
Current Cancer Therapy Reviews Biology of Transforming Growth Factor-β Signaling
Current Pharmaceutical Biotechnology Therapeutic Strategies to Target Multiple Kinases in Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry NK-1 Receptor Antagonists: A New Generation of Anticancer Drugs
Mini-Reviews in Medicinal Chemistry Corticotropin Releasing Factor (CRF) Receptor Signaling in the Central Nervous System: New Molecular Targets
CNS & Neurological Disorders - Drug Targets